An Overview of Testosterone Therapy
- PMID: 25398416
- DOI: 10.1177/1557988314556671
An Overview of Testosterone Therapy
Abstract
Millions of men, as a result of the natural aging process, injury, illness, and medical therapies, experience a decline in testosterone levels that necessitate a need for testosterone supplementation therapy (TST). The signs and symptoms of testosterone decline may occur gradually, and low testosterone levels may be misdiagnosed as other medical conditions. Over the past two decades, there has been an increase in testing of testosterone levels and the use of TST. With so many men now on TST, it is essential for health care professionals to know the signs and symptoms, the causes of testosterone decline, how testosterone deficiency is diagnosed, what pathological changes are associated with testosterone decline, and the benefits and risks of TST. In addition, health care providers need to be aware of the various forms of testosterone available as well as the advantages and disadvantages of each. This article provides a brief overview of testosterone deficiency, TST treatment options and guidelines, and the risks and benefits associated with of TST.
Keywords: development and aging; health awareness; health screening; hypogonadism.
© The Author(s) 2014.
Similar articles
-
Testosterone replacement therapy: who to evaluate, what to use, how to follow, and who is at risk?Hosp Pract (1995). 2014 Dec;42(5):69-82. doi: 10.3810/hp.2014.12.1160. Hosp Pract (1995). 2014. PMID: 25485919 Review.
-
Androgen deficiency in older men: indications, advantages, and pitfalls of testosterone replacement therapy.Cleve Clin J Med. 2012 Nov;79(11):797-806. doi: 10.3949/ccjm.79a.12010. Cleve Clin J Med. 2012. PMID: 23125330 Review.
-
Testosterone deficiency syndrome: benefits, risks, and realities associated with testosterone replacement therapy.Can J Urol. 2016 Feb;23(Suppl 1):20-30. Can J Urol. 2016. PMID: 26924592
-
Hypotestosteronaemia in the aging male: should we treat it?Swiss Med Wkly. 2015 Nov 24;145:w14216. doi: 10.4414/smw.2015.14216. eCollection 2015. Swiss Med Wkly. 2015. PMID: 26599486 Review.
-
Testosterone and ageing: what have we learned since the Institute of Medicine report and what lies ahead?Int J Clin Pract. 2007 Apr;61(4):622-32. doi: 10.1111/j.1742-1241.2007.01317.x. Epub 2007 Mar 2. Int J Clin Pract. 2007. PMID: 17343664 Review.
Cited by
-
Potent inhibitors of equine steroid isomerase EcaGST A3-3.PLoS One. 2019 Mar 21;14(3):e0214160. doi: 10.1371/journal.pone.0214160. eCollection 2019. PLoS One. 2019. PMID: 30897163 Free PMC article.
-
Testosterone attenuates hypoxia-induced hypertension by affecting NRF1-mediated transcriptional regulation of ET-1 and ACE.Hypertens Res. 2021 Nov;44(11):1395-1405. doi: 10.1038/s41440-021-00703-4. Epub 2021 Jul 13. Hypertens Res. 2021. PMID: 34257425
-
Falsely elevated serum testosterone measurements resulting from testosterone topical gel contamination of the venipuncture site: Case Series and retrospective review.Heliyon. 2023 Nov 24;9(12):e22819. doi: 10.1016/j.heliyon.2023.e22819. eCollection 2023 Dec. Heliyon. 2023. PMID: 38094062 Free PMC article.
-
Mitochondria in Sex Hormone-Induced Disorder of Energy Metabolism in Males and Females.Front Endocrinol (Lausanne). 2021 Dec 20;12:749451. doi: 10.3389/fendo.2021.749451. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34987473 Free PMC article. Review.
-
Effectiveness of testosterone therapy in obese men with low testosterone levels, for losing weight, controlling obesity complications, and preventing cardiovascular events: Protocol of a systematic review of randomized controlled trials.Medicine (Baltimore). 2018 Apr;97(17):e0482. doi: 10.1097/MD.0000000000010482. Medicine (Baltimore). 2018. PMID: 29703008 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous